| 3368 |
National Human Genome Research Institute |
Html |
null |
From the Blueprint to You |
Created in April 2003 for 50 years of DNA: A Celebration of the Genome, From the Blueprint to You explores the world of genetics, DNA, the Human Genome Project, the ethical, legal and social implications of genetic research and the future of genomics. |
|
|
CLICK HERE |
| 15540 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
NIAID Paylines -- NIAID Research Funding |
Fiscal year paylines for all award types. |
| Final NIAID Paylines | 0.905895 |
| POs contact information | 0.229921 |
| interim paylines | 0.666704 |
| success rates | 0.214968 |
| Email Alerts | 0.25735 |
| NIAID funds | 0.432012 |
|
| Research Project Success | 0.236611 |
| program officer | 0.217587 |
| overall impact/priority score | 0.255863 |
| initial paylines | 0.594349 |
| Research Portfolio Online | 0.237047 |
|
CLICK HERE |
| 15545 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Methicillin-Resistant Staphylococcus aureus MRSA, Antimicrobial Resistance |
NIAID conducts and supports research on methicillin-resistant Staphylococcus aureus, MRSA--drug-, or antimicrobial-, resistant bacteria that has become a serious public health concern. |
| Allergy | 0.341577 |
| Require | 0.335974 |
| Experts | 0.328592 |
| Research > Antimicrobial | 0.486656 |
| Pathway | 0.34693 |
| methicillin-resistant staphylococcus aureus | 0.971182 |
| controllable nuisance | 0.508668 |
| HIV Vaccine | 0.518468 |
| NIAID-Supported Institutions | 0.464562 |
| Research > NIAID | 0.500955 |
| MRSA | 0.488992 |
| News | 0.326356 |
| new strains | 0.473848 |
|
| Universal Influenza Vaccine | 0.682447 |
| HIV/AIDS Pandemic Likely | 0.665604 |
| public health concern | 0.611156 |
| National Institute | 0.496139 |
| NIH | 0.350088 |
| allergic diseases | 0.501528 |
| severe infections | 0.473944 |
| Role | 0.327169 |
| Infectious Diseases | 0.524019 |
| decades | 0.338877 |
| hospital-acquired infection | 0.507902 |
| Durable End | 0.489538 |
|
CLICK HERE |
| 15548 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Tuberculosis TB, NIAID, NIH |
NIAID is examining TB at its fundamental levels through research to develop faster diagnosis, better vaccines, and shorter treatment times. |
| animal models | 0.484339 |
| treatment strategies | 0.479645 |
| new TB drug | 0.750789 |
| drug-resistant strains | 0.584127 |
| multidrug-resistant TB | 0.705257 |
| optimal drug combinations | 0.547291 |
| TB disease | 0.789313 |
| research findings | 0.480296 |
| severe airborne disease | 0.575915 |
| research | 0.505253 |
| new candidate drugs | 0.571748 |
| death worldwide | 0.485014 |
| novel TB drugs | 0.766874 |
| national history | 0.484991 |
| candidate drugs | 0.572469 |
| active TB disease | 0.746928 |
| TB deaths | 0.714042 |
| major causes | 0.487119 |
| MedlinePlus tuberculosis site | 0.583865 |
| genetic drug | 0.486206 |
| comprehensive portfolio | 0.485226 |
| TB bacterium | 0.688383 |
| latent infections | 0.478461 |
| middle-income countries | 0.49248 |
|
| risk factors | 0.478783 |
| World Health Organization | 0.559465 |
| research infrastructure | 0.479568 |
| early TB disease | 0.745692 |
| NIAID | 0.606471 |
| diagnostic potential | 0.480354 |
| people | 0.530993 |
| TB | 0.982786 |
| biomedical research | 0.486422 |
| new TB drugs | 0.754513 |
| HIV deaths | 0.484548 |
| Mycobacterium tuberculosis | 0.614224 |
| private industry | 0.478347 |
| public health practices | 0.540649 |
| TB diagnosis | 0.691172 |
| clinical studies | 0.55766 |
| prevention strategies | 0.478336 |
| NIAID priority | 0.54559 |
| vaccine clinical trials | 0.538763 |
| Mtb | 0.530457 |
| drug resistance | 0.554266 |
| causative agent | 0.484545 |
| basic research | 0.485797 |
|
CLICK HERE |
| 15549 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Antimicrobial Drug Resistance, NIAID, NIH |
NIAID supports and conducts research on many aspects of antimicrobial (drug) resistance, or antibiotic resistance, from basic research to clinical trials. |
| new vaccines | 0.274623 |
| infectious diseases | 0.279195 |
| antimicrobial drug treatment | 0.492562 |
| drug-resistant microbes | 0.325369 |
| antimicrobial resistance | 0.928016 |
| infectious organisms | 0.275735 |
| research portfolio | 0.351624 |
| supports research | 0.304893 |
| clinical trials | 0.277383 |
| antimicrobial drug | 0.516315 |
| NIAID laboratories | 0.477113 |
| NIAID-supported research | 0.295594 |
| clinical research | 0.369869 |
| important clinical questions | 0.324644 |
| open NIAID Requests | 0.530136 |
| NIAID Funding Opportunities | 0.523623 |
| NIAID research | 0.580865 |
| hospital-acquired infections | 0.274304 |
| Clinical research projects | 0.349601 |
| drug-resistant Staphylococcus aureus | 0.333068 |
| NIAID conducts | 0.508062 |
| faster diagnostics | 0.275989 |
| Institute’s research | 0.298397 |
| resistant diseases NIAID | 0.561618 |
|
| NIAID researchers | 0.477146 |
| novel prevention strategies | 0.319996 |
| antimicrobial drugs | 0.69881 |
| NIAID research efforts | 0.571105 |
| new antimicrobial therapeutics | 0.459619 |
| public health threats | 0.318497 |
| NIAID’s Antibacterial | 0.53608 |
| Antibacterial Research Program | 0.46669 |
| basic research discoveries | 0.353884 |
| NIAID plans | 0.499656 |
| public health | 0.32965 |
| clinical research activities | 0.348221 |
| antibacterial resistance | 0.553694 |
| NIAID | 0.879483 |
| latest scientific advances | 0.326471 |
| biomedical research | 0.290746 |
| microbes | 0.351855 |
| public health efforts | 0.319101 |
| Research Program accomplishments | 0.354154 |
| antimicrobial resistance research | 0.617628 |
| NIAID efforts | 0.478833 |
| Antibacterial Resistance Leadership | 0.484882 |
| basic research | 0.461234 |
| drug resistant diseases | 0.437539 |
|
CLICK HERE |
| 15550 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Intramural NIAID Research Opportunities INRO, NIH |
INRO is an NIAID 4-day exploratory program that connects minority science students with training opportunities in immunology and infectious diseases. |
| INRO email updates | 0.738453 |
| financially disadvantaged backgrounds | 0.982393 |
| multi-disciplinary research facility | 0.838981 |
| recent hurricanes | 0.496559 |
| medical students | 0.522578 |
| research training experience | 0.829391 |
| program | 0.227182 |
|
| NIAID | 0.411192 |
| biomedical research | 0.532386 |
| hardship | 0.209827 |
| hotel accommodations | 0.500268 |
| application process | 0.466663 |
| difficult time | 0.488892 |
| diverse research community | 0.837556 |
|
CLICK HERE |
| 15554 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Biodefense Category A, B, C Pathogens |
NIAID biodefense Category A, B, C pathogens |
| Additional Emerging Infectious | 0.832106 |
| Centers | 0.421008 |
| host defenses | 0.530437 |
| United States | 0.52892 |
| NIAIDÂ biodefense/EID mission | 0.732951 |
| highest priority | 0.718109 |
| Category C pathogens | 0.679223 |
| Biodefense Research | 0.623199 |
| U.S. Department | 0.53081 |
| complete scope | 0.522633 |
| Prevention | 0.420958 |
| conjunction | 0.425199 |
| Disease Control | 0.527974 |
| geographic range | 0.544192 |
| Emerging Infectious Diseases/Pathogens | 0.964432 |
| priority pathogens | 0.731074 |
| public health | 0.526578 |
| Notes | 0.420393 |
| pathogen threats | 0.55739 |
|
| national security | 0.524884 |
| HIV/AIDS | 0.422564 |
| Diseases/Pathogens category | 0.607089 |
| federal partners | 0.531115 |
| NIAID Emerging Infectious | 0.962085 |
| priority organisms/biological agents | 0.689595 |
| Category B pathogens | 0.686236 |
| Homeland Security | 0.535344 |
| intramural program management | 0.634748 |
| revision | 0.425668 |
| population | 0.422041 |
| NIAID Category | 0.742626 |
| biodefense effort | 0.588256 |
| highest risk | 0.556143 |
| pathogen priority list | 0.734849 |
| mass dissemination | 0.523841 |
| threat assessments | 0.532316 |
| Immunology studies | 0.522128 |
|
CLICK HERE |
| 15804 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Food Allergy |
NIAID supports food allergy research, which spans the spectrum from basic research in allergy and immunology to clinical trials that are testing new strategies to treat and prevent food allergy. |
| prevention options | 0.339349 |
| ongoing clinical trials | 0.370651 |
| lead Institute | 0.347558 |
| NIAID-funded scientists | 0.33777 |
| new strategies | 0.345355 |
| current evidence-based recommendations | 0.370416 |
| policy report | 0.342135 |
| immune responses | 0.337553 |
| children | 0.321267 |
| faster rate | 0.335898 |
| observational studies | 0.345615 |
| significant progress | 0.335698 |
| practical ways | 0.34177 |
| National Institutes | 0.383015 |
| risk factors | 0.342668 |
| Personal medical history | 0.374798 |
| NIAID-supported study | 0.337131 |
| important role | 0.337607 |
| eosinophilic esophagitis | 0.3439 |
| United States | 0.385897 |
| allergic conditions | 0.339157 |
| common allergens plays | 0.380868 |
| gut bacteria | 0.371845 |
| Drug Administration | 0.341666 |
| scientific community | 0.339254 |
|
| food allergies | 0.381405 |
| NIAID researchers | 0.401866 |
| allergy clinical trials | 0.47886 |
| life-threatening response | 0.347529 |
| basic studies | 0.337145 |
| early introduction | 0.341065 |
| experimental immunotherapies | 0.343557 |
| new treatments | 0.33937 |
| careful monitoring | 0.340519 |
| active clinical trials | 0.373969 |
| baked milk | 0.396405 |
| NIAID-funded study | 0.336779 |
| comprehensive food allergy | 0.510173 |
| NIAID | 0.483382 |
| food allergy | 0.951641 |
| milk allergy foods | 0.4779 |
| biomedical research | 0.341796 |
| Clinical Immunology | 0.339341 |
| National Academies | 0.341431 |
| food allergy research | 0.643116 |
| family history | 0.340464 |
| oral allergy syndrome | 0.484032 |
| food allergens | 0.388332 |
| expert panel | 0.337968 |
|
CLICK HERE |
| 15980 |
National Institute of Allergy and Infectious Diseases |
Video |
en |
Understanding Food Allergy |
The National Institute of Allergy and Infectious Diseases explains food allergy and offers tips on how to manage the condition. |
| TEDx Talks | 0.301209 |
| Food Allergy Enigma | 0.427335 |
| WARNING Signs | 0.307007 |
| Allergy Skin Tests | 0.422724 |
| ABS-CBN News | 0.319963 |
| Food Allergies | 0.800849 |
| Steve Paikin | 0.306473 |
| tips | 0.220462 |
| Untreated allergic reactions | 0.428934 |
| Mo10ta | 0.219842 |
| Anaphylaxis-Mayo Clinic | 0.294736 |
| Severe Food Allergies | 0.523532 |
| Sonia Hunt | 0.304266 |
| Duration | 0.977395 |
| Good Morning | 0.305532 |
| Dr. John Bergman | 0.374323 |
| eMedTV | 0.221562 |
| Stay Safe | 0.301006 |
| symptoms | 0.217567 |
| condition | 0.220423 |
| Infectious Diseases | 0.318448 |
| Foods | 0.218524 |
| Food Allergens | 0.31897 |
| Live Healthy | 0.301596 |
| Gluten Intolerance | 0.31617 |
|
| Mayo Clinic | 0.294446 |
| Cure Allergies FAST | 0.483591 |
| Signature Medical Group | 0.391029 |
| Food Intolerances | 0.341701 |
| boy | 0.235485 |
| Allergies Are Tired | 0.41865 |
| ABC News | 0.406616 |
| America | 0.2185 |
| Food Can Kill | 0.320007 |
| Severe Food Allergy | 0.452133 |
| views | 0.647848 |
| National Institute | 0.318188 |
| Immune Response | 0.297675 |
| Sensitivities | 0.221006 |
| Agenda | 0.21749 |
| NIAID | 0.224612 |
| food allergy | 0.513642 |
| Food Control Plan | 0.393618 |
| TEDxUCDavisSF | 0.217779 |
| Fatal Allergies | 0.417301 |
| National Geographic | 0.373164 |
| Rita Mustafa | 0.302426 |
| PsycheTruth | 0.219651 |
| Ana Pena | 0.303769 |
|
CLICK HERE |
| 15981 |
National Institute of Allergy and Infectious Diseases |
Video |
en |
Influenza: Get the (Antigenic) Drift |
Have you ever wondered why you need a flu vaccination each year? The National Institute of Allergy and Infectious Diseases explains the ever-changing nature of influenza viruses. |
| Action MOA Animation | 0.579913 |
| Shomu | 0.416725 |
| Allergy | 0.416577 |
| SwineFlu | 0.416001 |
| Daniel Levy | 0.496516 |
| flutube100 | 0.416238 |
| Osmosis | 0.416074 |
| H1N1 Swine Flu | 0.627108 |
| Unpredictable Threat | 0.498722 |
| flu vaccination | 0.597572 |
| milos velja | 0.493184 |
| World Health Organization | 0.57148 |
| 1918 Flu Pandemic | 0.627835 |
| flu virus mechanism | 0.693678 |
| reverse transcriptase | 0.494547 |
| Duration | 0.949875 |
| Virus Invades | 0.512664 |
| AMAZING DOCUMENTARY | 0.485888 |
| autoplay | 0.453443 |
| HIV life cycle | 0.567135 |
| Carolyn Bertozzi | 0.598025 |
| Infectious Diseases | 0.507143 |
| Influenza H1N1 Mechanism | 0.7022 |
| VIRUS EVOLUTION | 0.501245 |
| antigenic shift | 0.607123 |
|
| influenza | 0.762967 |
| 720p | 0.423131 |
| iBioEducation | 0.42898 |
| Influenza animation | 0.642901 |
| Influenza Pandemics Occur | 0.718554 |
| Biology | 0.416713 |
| video | 0.418444 |
| Genetic Shift | 0.503494 |
| Berkeley/HHMI | 0.429072 |
| ever-changing nature | 0.51424 |
| views | 0.737316 |
| National Institute | 0.509002 |
| Fighting flu | 0.555906 |
| Influenza infection model | 0.670194 |
| Immune Response | 0.487687 |
| David Hager | 0.509045 |
| Scientific Animations | 0.498803 |
| DOCUMENTARY TUBE | 0.482643 |
| NIAID | 0.456714 |
| Influenza Virus Infection | 0.688245 |
| Flu Attack | 0.564409 |
| influenza viruses | 0.646604 |
| Nucleus Medical Media | 0.585917 |
| Million People | 0.484786 |
|
CLICK HERE |